Clinical Trial Update: Trial of Nilotinib and Adriamycin as Treatment in Liposarcomas and Leiomyosarcomas of Retroperitoneum [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on a Phase 1/2 study of nilotinib in combination with Adriamycin for retroperitoneal liposarcoma and retroperitoneal leiomyosarcoma. The c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retroperitoneal Leiomyosarcoma
• Retroperitoneal Liposarcoma

Drugs mentioned

• Adriamycin (doxorubicin)
• Nilotinib (nilotinib)

Snippet

Sponsor: Broto, Javier Martín, M.D. | Conditions: Retroperitoneal Liposarcoma, Retroperitoneal Leiomyosarcoma | Phase 1, Phase 2 | Status: UNKNOWN